Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-04
2005-10-04
Aulakh, Charanjit S. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C544S247000, C514S285000, C514S257000
Reexamination Certificate
active
06951942
ABSTRACT:
Compounds having Formula Iare useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of inhibiting immune or autoimmune diseases in a mammal.
REFERENCES:
patent: 3719667 (1973-03-01), Gutowski
patent: 3840556 (1974-10-01), Kukolja
patent: 5688808 (1997-11-01), Jones et al.
patent: 5688810 (1997-11-01), Jones et al.
patent: 5693133 (1997-12-01), Largent et al.
patent: 5693646 (1997-12-01), Jones et al.
patent: 5693647 (1997-12-01), Jones et al.
patent: 5696127 (1997-12-01), Jones et al.
patent: 5696130 (1997-12-01), Jones et al.
patent: 6506766 (2003-01-01), Coghlan et al.
patent: WO-96/19458 (1996-06-01), None
patent: WO-99/41256 (1999-08-01), None
Berge, S.,et al. , “Review Article—Pharmaceutical Salts”,Journal of Pharmaceutical Sciences,66,(1977),pp. 1-19.
Edwards, J., et al. , “5-Aryl-1,2-dihydro-5H-chromeno [3,4-f]quinolines as Potent, Orally Active, Nonsteroidal Progesterone Receptor Angonists: The Effect of D-Ring Substituents”,J. Med. Chem.,41, (1998),pp. 303-310.
Erdos, T.,et al. , “A rapid essay for binding estradiol to uterine receptor(s)”,Analytical Biochemistry, 37, (1970),pp. 244-252.
Coghlan Michael J.
Edwards James P.
Elmore Steven W.
Jones Todd K.
Kort Michael E.
Abbott Laboratories
Ligand Pharmaceuticals Incorporated
Pillsbury & Winthrop LLP
LandOfFree
Glucocorticoid-selective anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucocorticoid-selective anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocorticoid-selective anti-inflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461470